These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide. Bärtsch P; Schneider M BMJ; 2001 Jan; 322(7277):48-9. PubMed ID: 11141168 [No Abstract] [Full Text] [Related]
45. [Diagnosis and therapy of acute altitude sickness]. Berghold F Wien Med Wochenschr; 2000; 150(8-9):169-74. PubMed ID: 10960957 [TBL] [Abstract][Full Text] [Related]
46. Pharmacologic prevention for acute mountain sickness-lack of appropriate inclusion of the available evidence. Lipman GS; Gertsch JH Ann Emerg Med; 2012 Oct; 60(4):538-9. PubMed ID: 23010187 [No Abstract] [Full Text] [Related]
47. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment. Stream JO; Grissom CK Wilderness Environ Med; 2008; 19(4):293-303. PubMed ID: 19099331 [TBL] [Abstract][Full Text] [Related]
48. Travelling safely to places at high altitude - Understanding and preventing altitude illness. Parise I Aust Fam Physician; 2017 Jun; 46(6):380-384. PubMed ID: 28609593 [TBL] [Abstract][Full Text] [Related]
49. Acetazolamide and prevention of acute mountain sickness. Prescrire Int; 2014 Nov; 23(154):273. PubMed ID: 25954800 [TBL] [Abstract][Full Text] [Related]
50. Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema. Joyce KE; Lucas SJE; Imray CHE; Balanos GM; Wright AD Expert Opin Pharmacother; 2018 Dec; 19(17):1891-1902. PubMed ID: 30307756 [TBL] [Abstract][Full Text] [Related]
51. Mountain sickness. Elnicki DM W V Med J; 1990 Jun; 86(6):246-9. PubMed ID: 2194372 [TBL] [Abstract][Full Text] [Related]
52. Delayed-Onset High Altitude Pulmonary Edema: A Case Report. Bhattarai A; Acharya S; Yadav JK; Wilkes M Wilderness Environ Med; 2019 Mar; 30(1):90-92. PubMed ID: 30642713 [TBL] [Abstract][Full Text] [Related]
53. [Travelling to high altitude areas--acute high altitude sickness]. Rostrup M Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1692-4. PubMed ID: 12555615 [TBL] [Abstract][Full Text] [Related]
55. [Etiology, clinical aspects and therapy of altitude sickness]. Berghold F; Schobersberger W Wien Med Wochenschr; 1994; 144(7):125-9. PubMed ID: 8073777 [TBL] [Abstract][Full Text] [Related]
57. Failed mountain sickness prophylaxis. Crowley JS; Straughan CA; Lee V; Johnson PA J R Army Med Corps; 1998 Feb; 144(1):48-9. PubMed ID: 9694020 [No Abstract] [Full Text] [Related]
58. Acetazolamide and dexamethasone in the prevention of acute mountain sickness. Zell SC; Goodman PH West J Med; 1988 May; 148(5):541-5. PubMed ID: 3051673 [TBL] [Abstract][Full Text] [Related]
59. Ginkgo biloba and acetazolamide for acute mountain sickness: exclusion of high risk, low status groups perpetuates discrimination and inequalities. Adams J BMJ; 2004 Jul; 329(7458):171; author reply 172. PubMed ID: 15258082 [No Abstract] [Full Text] [Related]
60. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Moraga FA; Flores A; Serra J; Esnaola C; Barriento C Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]